STOCK TITAN

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (SIX:OCS) announced a notification dated November 18, 2025 reporting a purchase of ordinary shares by a member of the company's Board of Directors.

The notice references an attachment named notification-of-managers-transaction-lionel-carnot-november-2025, indicating the transaction involves director Lionel Carnot.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-0.08%
1 alert
-0.08% News Effect

On the day this news was published, OCS declined 0.08%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors.

Attachment


FAQ

What did Oculis (OCS) announce on November 18, 2025 regarding insider purchases?

Oculis announced a notification of a purchase of ordinary shares by a member of its Board of Directors dated November 18, 2025.

Which director is named in the Oculis managers' transaction notification on Nov 18, 2025?

The attached notification filename references Lionel Carnot, indicating the purchase involves that board member.

Does the Oculis Nov 18, 2025 notice disclose the number of shares bought (OCS)?

The brief notice does not include share quantity; it references an attachment for transaction details.

Where can investors find details of the Oculis (OCS) director purchase announced Nov 18, 2025?

Investors should consult the referenced attachment titled notification-of-managers-transaction-lionel-carnot-november-2025 for full transaction details.

Is the Nov 18, 2025 Oculis disclosure a mandatory managers' transaction notification?

Yes; the announcement is presented as a managers' transaction notification regarding a board member's share purchase.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.54B
50.32M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug